PubMed · 10339967
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
T Luostarinen. 1999. Methods for correcting risk estimates.. https://pubmed.ncbi.nlm.nih.gov/10339967/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
OBJECTIVES: To explore the relation between ill health after the Gulf war and vaccines received before or during the conflict. To test the hypothesis that such ill health is limited to military personnel who received multiple vaccines during deployment and that pesticide use modifies any effect. DESIGN: Cross sectional study of Gulf war veterans followed for six to eight years after deployment. SETTING: UK armed forces. PARTICIPANTS: Military personnel who served in the Gulf and who still had their vaccine records. MAIN OUTCOME MEASURES: Multisymptom illness as classified by the Centers for Disease Control and Prevention; fatigue; psychological distress; post-traumatic stress reaction; health perception; and physical functioning. RESULTS: The response rate for the original survey was 70.4% (n=3284). Of these, 28% (923) had vaccine records. Receipt of multiple vaccines before deployment was associated with only one of the six health outcomes (post-traumatic stress reaction). By contrast five of the six outcomes (all but post-traumatic stress reaction) were associated with multiple vaccines received during deployment. The strongest association was for the multisymptom illness (odds ratio 5.0; 95% confidence interval 2.5 to 9.8). CONCLUSION: Among veterans of the Gulf war there is a specific relation between multiple vaccinations given during deployment and later ill health. Multiple vaccinations in themselves do not seem to be harmful but combined with the "stress" of deployment they may be associated with adverse health outcomes. These results imply that every effort should be made to maintain routine vaccines during peacetime.
BACKGROUND: The problem considered is the quantitative comparison of immunofluorescence frequency distributions in order to detect their differences of biological significance, i.e., to evaluate the potential positivity of a cell sample with respect to negative control cells. The Kolmogorov-Smirnov (KS) statistical test, proposed in the literature for this purpose, is examined and discussed through its application to a set of experimental measurements. It is shown that even differences due to the stain procedure or to instrumental biases may be considered significant by the test implemented in the standard form. METHODS: In order to ensure valid results, it is necessary to take into account the various sources of variation in the specific experimental context. A procedure is proposed that uses the KS statistics as a reference for determining an appropriate estimate of the overall variability in the control data. This estimate is derived from the comparisons of the cumulative distributions associated with repeated measurements of the negative cell sample. RESULTS AND CONCLUSIONS: The KS-related index thus defined provides a tool for assessing the potential positivity of a cell sample, since it allows to distinguish between statistical and biological significance of the difference between the histogram to be tested and the set of control data. In particular, if a cell sample is not included in the control variability, either a positive cell subpopulation is present, or all cells are positive. Instead, for a sample included in the control variability, the difference will be not biologically meaningful, even if statistically significant. Moreover, when a purely positive control sample is also available, it is possible to derive a measure of the precision at which a true biological positivity can be detected. Finally, since the index is not absolute, but relative to the features of the instrumentation, of the antibodies and of the fluorochromes used, it represents a quantitative measure of the stability and reproducibility of the measurement process and could be used for quality control of flow cytometric experiments in immunofluorescence.
Explore the source record for details and available documents.